FDA approves controversial women’s libido drug
The Food and Drug Administration approved a controversial drug meant to increase women’s desire for sex, a treatment that has rekindled a debate over the limits of medicine when it comes to human sexuality.
The drug, called Vyleesi, is an under-the-skin injection women take before sex. It’s approved for women with hypoactive sexual desire disorder, or HSDD, which is defined as a distressing loss of interest in sex.
Read Original Article: FDA approves controversial women’s libido drug »
